Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization
Taketoshi Mizutani, Aya Ishizaka, Michiko Koga, Kazuhiko Ikeuchi, Makoto Saito, Eisuke Adachi, Seiya Yamayoshi, Kiyoko Iwatsuki‐Horimoto, Atsuhiro Yasuhara, Hiroshi Kiyono, Tetsuro Matano, Yutaka Suzuki, Takeya Tsutsumi, Yoshihiro Kawaoka, Hiroshi Yotsuyanagi
Abstract
There is growing evidence that the commensal microbiota of the gastrointestinal and respiratory tracts regulates local and systemic inflammation (gut-lung axis). COVID-19 is primarily a respiratory disease, but the involvement of microbiota changes in the pathogenesis of this disease remains unclear. The composition of the gut microbiota of patients with COVID-19 changed over time during hospitalization, and the intestines tended to be an aerobic environment in hospitalized COVID-19 patients. These changes in gut microbiota may induce increased intestinal permeability, called leaky gut, allowing bacteria and toxins to enter the circulatory system and further aggravate the systemic inflammatory response. Since gut microbiota composition correlates with levels of proinflammatory cytokines, this finding highlights the need to understand how pathology relates to the gut environment, including the temporal changes in specific gut microbiota observed in COVID-19 patients.